. Archives of Disease in Childhood, 51, 680 . Role of chronic hepatitis in development of thalassaemic liver disease. Liver function and the presence of HBsAg and anti-HBsAg were studied in 90 hypertransfused thalassaemic children. Increased serum transaminases were found in 62 patients, and persisted for more than 6 months in 45 cases. Liver biopsy in this latter group led to a diagnosis of 14 cases of chronic persistent hepatitis, 9 cases of aggressive hepatitis, and 3 cases of hepatic fibrosis. In Italy thalassaemic children undergoing hypertransfusion therapy frequently encounter SH virus infection, with a consequent hepatitis that is generally anicteric and unrecognized unless systematically sought. In a liver already stressed by the concomitant iron overload, hepatitis infection might thus play a key role in the evolution of cirrhosis which frequently affects thalassaemics.
The picture of thalassaemia has markedly changed in the last few years because of a more correct transfusion therapy. Serious cardiopathy is seen later in the course of the disease, whereas more thalassaemics are succumbing to fatal hepatic cirrhosis (Beltrami and Nenci, 1969;  Ellis, Schulman, and Smith, 1954;  Giraud, Orsini, and Muratore, 1959; Panizon and Vullo, 1957;  Witzleben and Wyatt, 1961) . Hepatotoxic factors to which the liver of the thalassaemic child may be exposed include iron overload, chronic hypoxia, hepatic stasis, protein deficiency, and repeated viral infection, particularly with SH virus but knowledge is scanty on the role of each of these on the evolution of liver cirrhosis. 'What knowledge there is is based on necropsy findings, and only recently has liver biopsy in vivo allowed the systematic study of the development of liver disease (Risdon, Flynn, and Barry, 1973; Masera and Jean, 1973; Barry et al., 1974) . From these studies it has emerged that inflammatory changes develop in the liver compatible with a diagnosis of chronic hepatitis (Masera and Jean, 1973; Diebold and Camilleri, 1974) . Furthermore, the observations of Economidou et al. (1970) , Vierucci et al. (1972) , Kattamis et al. (1974) , and ourselves (Masera and Jean, 1973) Costantino, and Doglia, 1970) modified according to Prince, and two methods of immuno-osmoelectrophoresis (Costantino et al., 1972 Where serum transaminases were much increased, further biochemical tests were made, total and direct serum bilirubin, alkaline phosphatase, serum proteins (total and fractionated), 45-minute BSP retention, immunoglobulin levels, and the presence of LE factor, antinuclear factors, smooth muscle antibodies (immunofluorescence-indirect method) and migration inhibition factor (MIF) (Soborg and Bendixen, 1967) . Liver biopsy was carried out in patients with raised serum transaminase levels for more than 6 months (Chalmers and Alter, 1971) ; liver specimens were fixed in Bouin's liquid and in paraffin; these preparations were then stained with H & E with silver impregnation (Gomori) and by Perls's method.
The characteristic histological picture ofa thalassaemic liver, with an intense haemosiderosis, progressive fibrosis, and the presence of haemopoietic foci, made it necessary to evaluate the inflammatory status of each specimen using precise parameters of aggresiveness and chronicity of the hepatic lesion (Desmet and De Groote, 1974; Baggenstoss et al., 1972; Scheuer, 1968) .
Indices of aggressiveness. The extension of necrosis was graded as follows: focal necrosis (cellular pleomorphism, Councilman's bodies); the bridging effect; submassive necrosis (involvement of portions of adjacent lobules with evidence of piecemeal necrosis).
Indices of chronicity. The disproportionate enlargement of the portal spaces from which fibrotic septa arise, interlobularly or taking the place of entire hepatic lobules, these septa being more or less infiltrated by inflammatory cells which tend to invade the surrounding parenchyma with phenomena of piecemeal necrosis; an increase in number of bile canaliculi.
On the basis of such elements we have classified our cases as either chronic persistent hepatitis, chronic aggressive hepatitis, or fibrosis. It is likely that this histological picture, due to a multifactorial pathogenesis, has a prognostic and developmental significance different from similar histological patterns seen in nonthalassaemic patients.
Results
Increase in serum transaminases. Systematic monitoring (every 20-30 days) of SGOT and SGPT levels led to the discovery of increase in these enzymes to more than three times the normal values in a large proportion of cases (62/90). 3 of the cases developed a typical icteric hepatitis, the features of which were no different from those of hepatitis in nonthalassaemic children. All 3 cases were HBsAg positive, the first being so for only a few weeks and the other 2 for 34 and 36 months, respectively. In the remaining 59 cases of anicteric liver disease there was no clinical evidence to suggest an acute liver involvement.
In 45 of the 90 cases raised transaminases persisted for from 9 to 24 months.
Incidence of HBsAg and anti-HBsAg. Of the 90 cases examined, 9 (10%) were HBsAg positive. Transient evidence of HBsAg was found in 7 cases, but only in 2 cases was this antigen present a long time (34 and 36 months, respectively). Anti-HBsAg positivity was more frequently shown for prolonged periods (13 out of the 28 cases), yet this antibody was present for only a few weeks in the other 15 cases (Gazzola et al., 1974) .
Liver biopsy (Table I) . Liver biopsy was performed in 26 patients who had evidence of abnormally high transaminase levels for more than 6 months. The lesions were multiple and varied somewhat in different biopsy specimens from the same patient.
Hepatitis (Fig. 1) . In 23 out of the 26 cases inflammatory infiltrates and cellular necrosis were present. In 14 cases the diagnosis of persistent hepatitis was made since the inflammatory infiltrates were mainly in the portal spaces and in the fibrous tissue without invasion of the surrounding hepatic parenchyma. Frequently, small areas of focal necrosis with Councilman's bodies and mononuclear infiltrates were present within the hepatic lobule, but evidence of piecemeal necrosis was not seen. On the contrary, in 9 of the remaining cases piecemeal necrosis, bridging effect, areas of marked focal and/or submassive necrosis were observed accompanied by active or passive septa (Desmet and De Groote, 1974) . In these cases the diagnosis of aggressive hepatitis was made.
Fibrosis (Fig. 2) . In all 26 cases fibrosis was conspicuous, involving primarily the portal spaces from which fibrotic interlobular septa arise. Generally, the connective tissue bands, newlyformed or derived from the collapse of original reticulum, had mononuclear cell infiltrates. Only in 3 of those patients whose specimens were diagnosed as showing hepatic fibrosis were the fibrotic phenomena predominant over the inflammatory aspects. In these cases the bile canaliculi were increased in number, without, however, enough evidence of pseudolobular regeneration to permit a diagnosis of cirrhosis.
Siderosis. In all 26 cases massive siderotic pigmentation was noted (-+ + + according to the scale of Barry, 1974) Areas of hepatic haemopoiesis (Fig. 3) . Evidence of haemopoiesis was present in all cases. These areas were localized within the hepatic lobule and contained erythrobiasts and megakaryocytes; their localization within the hepatic lobule and their composition (lacking myelocytes) being similar to that found in fetal liver (Diebold and Camilleri, 1974; Du Bois, 1963) .
Summarizing conclusions, in hypertransfused thalassaemic patients signs of localized hepatitis, primarily in the portal spaces and periportal zones, are superimposed on a liver more or less extensively fibrotic. Less frequently the inflammatory infiltrate is located more towards the centre of the hepatic lobule, suggesting a histological picture like that described as chronic lobular hepatitis (Popper and Schaffner, 1971) .
Correlation between histological findings and HBsAg and anti-HBsAg (Table II) . Of the 14 cases with the histological picture of persistent hepatitis, only 3 were HBsAg positive and 6 antiHBsAg positive. On the other hand, in 8 of the 9 cases diagnosed as aggressive hepatitis both HBsAg and anti-HBsAg positivity were found, an indication that these patients had been infected with SH virus.
Immunological investigations (Table I) muscle antibodies were occasionally shown, but antinuclear factor was never noted. Interestingly, the migration inhibition factor was almost always positive in those cases with histological evidence of chronic aggressive hepatitis. It was not possible to formulate any conclusions on the modification of serum proteins since they are already considerably altered in thalassaemia, even in the absence of liver involvement.
Discussion The study of the liver in hypertransfused thalassaemic children has generally been performed on post-mortem specimens (Beltrami and Nenci, 1969; Ellis et al., 1954; Giraud et al., 1959; Panizon and Vullo, 1957; Witzleben and Wyatt, 1961) . These investigations have shown that the hepatic insufficiency of thalassaemics is due to the presence of haemochromatosis with fibrosis and hepatic cirrhosis. A few studies have been made using biopsy material (Risdon et al., 1973; Masera and Jean, 1973; Barry et al., 1974) but the initial stages of the hepatic lesions are poorly understood. Investigators have mainly concentrated on the massive deposits of ferrous pigment; sporadic reports have called attention to the mononuclear cell infiltrates, probably evidence of an inflammatory component in this hepatopathy (Beltrami and Nenci, 1969; Masera and Jean, 1973; Diebold and Camilleri, 1974; Necheles, 1974) . Attempts to delay the development of hepatic cirrhosis have been largely through the use of iron-chelating compounds ). Yet the problem of cirrhosis should not be entirely attributed to pigment overload. In animal experiments it has not been possible to cause cirrhosis by administering massive doses of iron alone; only if another hepatotoxic factor (ethionine, carbon tetrachloride) is added to treatment will experimental cirrhosis develop (Goldberg and Smith, 1960; Kent et al., 1964; Nath, Sood, and Nayak, 1972; Orfei et al., 1968) . These facts prompted us to consider other factors which might exert harmful effects on the liver of hypertransfused thalassaemic children. Previous reports have shown frequent SH virus infection in thalassaemics (Economidou et al., 1970; Kattamis et al., 1974; Masera and Jean, 1973; Vierucci et al., 1972) and undoubtedly repeated transfusion must expose the patients to infection with other hepatotropic viruses including cytomegalovirus (Prince et al., 1971 ) and other unidentified viruses responsible for a hepatitis with a prolonged incubation (Finstone et al., 1975) . It must also be considered that thalassaemic children might be more susceptible to hepatitis caused by virus A.
The hypothesis of a hepatitis causing hepatic damage, at least in some thalassaemics, has been confirmed by our findings. HBsAg and antiHBsAg were frequently shown in our thalassaemic patients, as in previous studies. Our findings relate to the studies carried out in Italy (Vierucci et al., 1972) , whereas in Greece (Kattamis et al., 1974 The various forms of chronic hepatitis seen in thalassaemic children have special features which are probably due to the gross iron overload. This iron might favour extension of the hepatic necrosis caused by virus or might prevent regeneration of the hepatocytes primitively injured. The liberation of ferric pigment in the inflamed tissue would also lead to a more intensive fibroblastic proliferation, and so help to promote cirrhosis.
Regarding the therapeutic implications of these observations, chelation therapy is logical and its efficacy proven . Steroid therapy may be of some benefit in particular cases; for instance, those characterized by a histological picture of chronic aggressivity. At present we are studying serial liver biopsies of patients with chronic aggressive hepatitis under steroid therapy, and hope to determine whether this type of therapy is capable of slowing the course of liver disease towards cirrhosis.
Finally, in order to prevent infection, transfused blood components must not contain hepatitis virus. This requires strict selection and screening of blood donors, more precise detection of HBsAg and antiHBsAg, and the use of frozen blood. 
